Article
A Host-Oriented Inhibitor of Junin Argentine Hemorrhagic Fever Virus Egress
13 Feb 2014
Abstract excerpt
UNLABELLED: There are currently no U.S. Food and Drug Administration (FDA)-approved vaccines or therapeutics to prevent or treat Argentine hemorrhagic fever (AHF). The causative agent of AHF is Junin virus (JUNV); a New World arenavirus classified as a National Institute of Allergy and Infectious Disease/Centers for Disease Control and Prevention category A priority pathogen. The PTAP late (L) domain motif within...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
